Copyright
©The Author(s) 2015.
World J Gastroenterol. Jul 28, 2015; 21(28): 8473-8477
Published online Jul 28, 2015. doi: 10.3748/wjg.v21.i28.8473
Published online Jul 28, 2015. doi: 10.3748/wjg.v21.i28.8473
Table 1 Approved molecular theranostics and nanoparticles in gastrointestinal cancers
| Molecular theranostics | Nanoparticles | |
| Gastric cancer | Her2neu | Polypeptide NP |
| Magnetic NP of iron | ||
| Triblock copolymer NP | ||
| Colon cancer | KRAS | Polymeric nanosphere Micelle particles |
| Metal semi-conductor NP | ||
| Gold NP | ||
| Pancreas cancer | Somatostatine receptors1 | Iron oxide NP |
| Gold coated iron oxide NP |
- Citation: Ghosn M, Kourie HR, Tabchi S. Gastrointestinal cancers in the era of theranostics: Updates and future perspectives. World J Gastroenterol 2015; 21(28): 8473-8477
- URL: https://www.wjgnet.com/1007-9327/full/v21/i28/8473.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i28.8473
